Cellular interactions between hematopoietic stem and progenitor cells (SC/Ps) and the hematopoietic microenvironment (HM) play a critical role in regulating hematopoiesis. At least three classes of molecules contribute to the maintenance of hematopoiesis. Cytokines and chemokines stimulate the survival, growth, and migration of SC/Ps. Adhesion molecules (AMs) support the physical association of SC/Ps within the hematopoietic niches and regulate growth, homing and mobilization of SC/Ps. Nevertheless, little is known about the signaling mechanisms that control SC/P functions downstream from these molecules. Identification of key intracellular signaling molecules and pathways involved in regulating SC/P functions will facilitate the design of specific molecular therapies for the treatment of malignancies involving defects in SC/P function. Our long-range goal is to understand signaling mechanisms that control growth and actin-based functions in SC/Ps. Understanding these mechanisms is critical to the biology of SC/P amplification, homing and mobilization for translational applications of transplantation and gene therapy of blood disorders. The objective of this application is to determine how Src family of signaling molecules regulate growth and actin-based functions in c-Kit+Scal+ Lin- cells. The central hypothesis of the application is that hematopoietic specific Src family kinase (SFK) possess both unique as well as overlapping mechanisms to regulate growth and actin-based functions in c- Kit+Sca-l+Lin- cells. Among the known SFKs, three highly homologous SFKs Lyn, Hck, and Fgr are expressed only in SC/Ps. Amino acid sequence differences in these molecules are restricted predominantly to the amino terminus region. Despite their sequence similarities, we will present preliminary data to support our hypothesis that SFKs differentially (positively and negatively) regulate the magnitude and duration of cytokine-mediated growth in SC/Ps in part via regulation of phosphatase activation. The SC/P phenotypic changes we have identified associated with Lyn-deficiency are apparent in spite of normal Hck and Fgr expression. How these hematopoietic SFKs differentially (positively and negatively) modulate SC/P growth and survival given their limited amino acid differences will constitute a focus of this proposal. Our preliminary observations also lead us to hypothesize that SFKs regulate actin-based functions in SC/Ps, including defective chemotaxis in vitro and redistribution in vivo of c-Kit+Lin-Sca-l+ cells. Our proposed studies will provide unique insights into the physiologic significance of Lyn, Hck, and Fgr SFKs in the regulation of SC/P growth and actin-based functions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL075816-02
Application #
6845682
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Thomas, John
Project Start
2004-01-01
Project End
2007-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
2
Fiscal Year
2005
Total Cost
$376,250
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pediatrics
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Palam, Lakshmi Reddy; Mali, Raghuveer Singh; Ramdas, Baskar et al. (2018) Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway. JCI Insight 3:
Ghosh, Joydeep; Kapur, Reuben (2017) Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia. Exp Hematol 50:13-21
Ghosh, Joydeep; Kobayashi, Michihiro; Ramdas, Baskar et al. (2016) S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance. J Clin Invest 126:2621-5
Kapur, Reuben; Shi, Jianjian; Ghosh, Joydeep et al. (2016) ROCK1 via LIM kinase regulates growth, maturation and actin based functions in mast cells. Oncotarget 7:16936-47
Goodwin, Charles B; Li, Xing Jun; Mali, Raghuveer S et al. (2014) PI3K p110? uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of JMML. Blood 123:2838-42
Martin, Holly; Mali, Raghuveer Singh; Ma, Peilin et al. (2013) Pak and Rac GTPases promote oncogenic KIT-induced neoplasms. J Clin Invest 123:4449-63
Nabinger, S C; Li, X J; Ramdas, B et al. (2013) The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo. Leukemia 27:398-408
Krishnan, Subha; Mali, Raghuveer Singh; Koehler, Karl R et al. (2012) Class I(A) PI3Kinase regulatory subunit, p85?, mediates mast cell development through regulation of growth and survival related genes. PLoS One 7:e28979
Wen, Qiang; Goldenson, Benjamin; Silver, Serena J et al. (2012) Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell 150:575-89
Krishnan, Subha; Mali, Raghuveer Singh; Ramdas, Baskar et al. (2012) p85? regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis. Blood 119:3951-61

Showing the most recent 10 out of 29 publications